Stockreport

Biodesix Details Lung Test Momentum, 81% Gross Margin and Growth Plan at Barclays Conference [Yahoo! Finance]

Biodesix, Inc.  (BDSX) 
PDF decisioning and treatment guidance, and the company is expanding from pulmonology into primary care referral networks. Biodesix reported 81% gross margins for the prio [Read more]